Please assess the completion status of the following clinical trial:

Trial Title: Metabolic Derangements in Acute Heart Failure Syndrome

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Adult (age \> 18 yrs) patients admitted to the Heart Failure Intensive Care Unit (H22) with Acute Heart Failure Syndrome (AHFS) requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.~Exclusion Criteria:~* History of Congenital Heart Disease.~* Acute HF in the setting of acute myocardial infarction.~* Severe Anemia~* Patients listed for cardiac transplantation.~* Terminal Malignancy, AIDS or CNS disease.~* Concomitant sepsis, ARDS, trauma, aortic dissection, or pericardial tamponade

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observation (Type: None): Adult (age \> 18 yrs) patients admitted to the Heart Failure Intensive Care Unit with Acute Heart Failure Syndrome requiring placement of a Pulmonary Artery catheter for hemodynamically guided therapy.

Based on this trial design, predict the completion outcome and termination type (if applicable).